Literature DB >> 18336742

Activation of interferon response genes and of plasmacytoid dendritic cells in HIV-1 positive subjects with GB virus C co-infection.

E Lalle1, A Sacchi, I Abbate, A Vitale, F Martini, G D'Offizi, G Antonucci, C Castilletti, F Poccia, M R Capobianchi.   

Abstract

GB virus C (GBV-C) coinfection has a protective role in Human Immunodeficiency Virus (HIV) infection, and increases the duration of suppression of HIV-1 viremia in patients under Highly Active Anti-Retroviral Therapy (HAART). Since innate antiviral response may be involved in the protection, we analyzed the possible role of GBV-C as activator of innate immunity. To this aim, we measured the extent of activation of the interferon (IFN) system and of circulating Dendritic Cells (DC) in vivo, and the ability of GBV-C to activate these functions in vitro. Activation of IFN system and of circulating DC was compared in GBV-positive and -negative HIV-1 co-infected patients with HAART-driven suppression of HIV-1 viremia. Endogenous levels of IFN-gamma and RNA-dependent protein kinase (PKR) mRNA were significantly higher in peripheral blood mononuclear cells (PBMC) from GBV-C-positive when compared to GBV-C-negative patients. IFN-gamma expression was correlated with all the Interferon response genes (IRGs) and with GBV-C viremia. The frequency of circulating plasmacytoid DC (pDC) expressing the CD80 activation marker was increased in GBV-C-positive patients, and was correlated with GBV-C viral load. In vitro experiments indicated that GBV-C is able to induce IFN-gamma expression in PBMC. In addition, in PBMC cultures GBV-C induced an increase of CD80 expression by pDC, that was reduced by antibody to IFN-gamma. Our data indicate that in HIV-positive patients GBV-C coinfection promotes the activation of IFN-gamma and downstream IRG expression, as well as with the activation/maturation of circulating pDC. GBV-C-driven IFN-gamma activation is, at least in part, responsible for the increased maturation of pDC. This crosstalk may suggest a role for GBV-C coinfection in boosting the innate antiviral response to HIV infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18336742     DOI: 10.1177/039463200802100118

Source DB:  PubMed          Journal:  Int J Immunopathol Pharmacol        ISSN: 0394-6320            Impact factor:   3.219


  11 in total

Review 1.  GBV-C: state of the art and future prospects.

Authors:  Maria Teresa Maidana Giret; Esper Georges Kallas
Journal:  Curr HIV/AIDS Rep       Date:  2012-03       Impact factor: 5.071

Review 2.  Role of GB virus C in modulating HIV disease.

Authors:  Carolynne Schwarze-Zander; Jason T Blackard; Juergen K Rockstroh
Journal:  Expert Rev Anti Infect Ther       Date:  2012-05       Impact factor: 5.091

3.  Cytokine/chemokine expression associated with Human Pegivirus (HPgV) infection in women with HIV.

Authors:  Jason T Blackard; Gang Ma; Jeffrey A Welge; Lynn E Taylor; Kenneth H Mayer; Robert S Klein; David D Celentano; Jack D Sobel; Denise J Jamieson; Caroline C King
Journal:  J Med Virol       Date:  2017-08-28       Impact factor: 2.327

4.  Current Views on the Pathophysiology of GB Virus C Coinfection with HIV-1 Infection.

Authors:  Esaki Muthu Shankar; Pachamuthu Balakrishnan; Ramachandran Vignesh; Vijayakumar Velu; Palanisamy Jayakumar; Suniti Solomon
Journal:  Curr Infect Dis Rep       Date:  2011-02       Impact factor: 3.725

Review 5.  GB virus C: the good boy virus?

Authors:  Nirjal Bhattarai; Jack T Stapleton
Journal:  Trends Microbiol       Date:  2012-02-08       Impact factor: 17.079

Review 6.  GB virus type C interactions with HIV: the role of envelope glycoproteins.

Authors:  Emma L Mohr; Jack T Stapleton
Journal:  J Viral Hepat       Date:  2009-09-15       Impact factor: 3.728

7.  Virus against virus (VIVI): a potential solution against HIV/AIDS.

Authors:  Asfandyar Sheikh; Muhammad Farhan Khaliq; Muhammad Muslim Noorani
Journal:  Int Arch Med       Date:  2014-05-06

Review 8.  Review of human pegivirus: Prevalence, transmission, pathogenesis, and clinical implication.

Authors:  Yaqi Yu; Zhenzhou Wan; Jian-Hua Wang; Xianguang Yang; Chiyu Zhang
Journal:  Virulence       Date:  2022-12       Impact factor: 5.882

Review 9.  Clinical and molecular aspects of human pegiviruses in the interaction host and infectious agent.

Authors:  Mehdi Samadi; Vahid Salimi; Mohammad Reza Haghshenas; Seyed Mohammad Miri; Seyed Reza Mohebbi; Amir Ghaemi
Journal:  Virol J       Date:  2022-03-09       Impact factor: 4.099

Review 10.  A systematic approach to virus-virus interactions.

Authors:  T DaPalma; B P Doonan; N M Trager; L M Kasman
Journal:  Virus Res       Date:  2010-01-20       Impact factor: 3.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.